Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 2,449 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implant Clear all

Conditions: Aortic Valve Disease
Interventions: Top Hat, Regent; Device
Lead sponsor: Sorin Group USA, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Baltimore, Maryland • Kingsport, Tennessee

Conditions: Hysterectomy
Interventions: Hysteroscopic device placement including Essure (ESS305, BAY1454032), Tubal ligation; Device · Procedure
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 10,578 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: New Jersey, New Jersey

Conditions: Peri-implant Mucositis
Interventions: Water Flosser, Manual Toothbrush; Device
Lead sponsor: Water Pik, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pregnancy
Interventions: Not listed
Lead sponsor: BioIncept LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Pacemaker, Implantable Cardioverter Defibrillators
Interventions: MRI; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 872 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mitral Valve Failure
Interventions: Edwards SAPIEN 3 transcatheter heart valve, ASHI INTECC Astato XS 20; Device
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 6
States / cities: Washington D.C., District of Columbia • Atlanta, Georgia • Detroit, Michigan + 3 more

Conditions: Sick Sinus Syndrome, Complete Heart Block, Syncope, Chronic Systolic Heart Failure
Interventions: polymixin/bacitracin, cephalexin, or levofloxacin, or clindamycin, Saline; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,010 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Ventricular Arrhythmias
Interventions: Implantation of subcutaneous ICD, Implantation of transvenous ICD; Device
Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Other
Eligibility: 18 Years and older
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2023
U.S. locations: 10
States / cities: New Haven, Connecticut • Atlanta, Georgia • Chicago, Illinois + 4 more

Conditions: Partial Edentulism, Tooth Disease
Interventions: Not listed
Lead sponsor: ZimVie; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Heart Failure, Heart Failure NYHA Class III, Heart Failure With Reduced Ejection Fraction, Ambulatory Heart Failure, NYHA Class IV
Interventions: PAS-C System; Device
Lead sponsor: InterShunt Technologies, Inc.; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 6
States / cities: Jonesboro, Arkansas • Thousand Oaks, California • Indianapolis, Indiana + 3 more

Conditions: Glaucoma, Open-Angle, Ocular Hypertension
Interventions: G2-TR intraocular implant containing travoprost, Sham surgery + active-comparator eye drops; Combination Product · Drug
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 560 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Congenital Heart Defects, Dysfunctional Right Ventricular Outflow Tract Conduits
Interventions: Transcatheter Pulmonary Valve replacement; Device
Lead sponsor: Medtronic Cardiovascular; Industry
Eligibility: 5 Years and older
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2020
U.S. locations: 5
States / cities: Miami, Florida • Boston, Massachusetts • New York, New York + 2 more

Conditions: Infertility
Interventions: Endometrial Receptivity Array analysis of endometrial biopsy; Other
Lead sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Palo Alto, California • Houston, Texas

Conditions: Dry Macular Degeneration, Geographic Atrophy
Interventions: CPCB-RPE1; Biological
Lead sponsor: Regenerative Patch Technologies, LLC; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 6
States / cities: Phoenix, Arizona • Beverly Hills, California • Los Angeles, California + 3 more

Conditions: Breast Reconstruction
Interventions: ARTIA Reconstructive Tissue Matrix; Device
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 23
States / cities: Los Angeles, California • Orange, California • Palo Alto, California + 20 more

Conditions: Pain, Orofacial
Interventions: Ibuprofen 200 mg and acetaminphen 650 mg, Ibuprofen 200 mg, Placebo oral tablet; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 80 Years
Enrollment: 375 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Stage D Heart Failure
Interventions: Sacubitril-Valsartan, Usual care (standard-of-care) arm; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Arthroplasty, Replacement, Hip
Interventions: Pelvic Alignment Level (PAL) Instrument, No Pelvic Alignment Level (PAL) Instrument; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Periprosthetic Fractures, Periprosthetic Fracture Around Prosthetic Joint Implant
Interventions: Not listed
Lead sponsor: AO Innovation Translation Center; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 4
States / cities: Columbia, Missouri • Jersey City, New Jersey • Livingston, New Jersey + 1 more

Conditions: Ectodermal Dysplasia, Jaw, Edentulous
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: Not listed
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1986 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Otitis Media, Otitis Media Chronic, Otitis Media Effusion, Otitis Media Recurrent, Otitis Media in Children
Interventions: CLiKX® Tympanostomy Tube Delivery System; Device
Lead sponsor: ClinQure, Inc.; Network
Eligibility: 6 Months and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Louisville, Kentucky • Houston, Texas • Mesquite, Texas + 1 more

Conditions: Penile Implantation
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Tooth Loss
Interventions: T3 Pro dental implant system; Device
Lead sponsor: ZimVie; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 2
States / cities: New Orleans, Louisiana • Minneapolis, Minnesota

Conditions: Pancreatic Cancer
Interventions: Device Arm with Therapeutic Agents; Combination Product
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Hyde Park, New York

Search by objective public record fields.

CarboMedics Top Hat vs St. Jude Medical Regent Valve Comparing Sizing and Hemodynamics

Proportion of Hysterectomy After Female Sterilization

Efficacy of an Oral Hygiene Implant Protocol

Correlation Between PIF Maternal Serum Levels and Pregnancy Outcome

Study Evaluating the Use of MRI on CMS Patients

NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation

Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.

A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy

A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

Clinical Study Comparing Two Models of a Travoprost Intraocular Implant

Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort

Incidence of Non Receptive Endometrium in Obese Women

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants

Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

Pelvic Alignment Level (PAL) Instrument Evaluation

Periprosthetic Fracture Registry (PPFx)

Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects

CLIKX® Tympanostomy Tube Delivery System for the Placement of Tympanostomy Tubes

Prosthetics Registry and Outcomes in Urology at Duke

An Observational Study of the T3 Pro Dental Implant System

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer